BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36308925)

  • 21. Establishing Synoptic Cancer Pathology Reporting in Low- and Middle-Income Countries: A Nicaraguan Experience.
    Valverde L D; Reznichek RC; Torres S M
    JCO Glob Oncol; 2022 Feb; 8():e1900343. PubMed ID: 35157509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathological Reporting of Radical Prostatectomy Specimens Following ICCR Recommendation: Impact of Electronic Reporting Tool Implementation on Quality and Interdisciplinary Communication in a Large University Hospital.
    Richter C; Mezger E; Schüffler PJ; Sommer W; Fusco F; Hauner K; Schmid SC; Gschwend JE; Weichert W; Schwamborn K; Pförringer D; Schlitter AM
    Curr Oncol; 2022 Sep; 29(10):7245-7256. PubMed ID: 36290848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Completeness of dictated operative reports in breast cancer--the case for synoptic reporting.
    Donahoe L; Bennett S; Temple W; Hilchie-Pye A; Dabbs K; Macintosh E; Porter G
    J Surg Oncol; 2012 Jul; 106(1):79-83. PubMed ID: 22234931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I-III Breast Cancer.
    Hsieh MC; Zhang L; Wu XC; Davidson MB; Loch M; Chen VW
    J Natl Compr Canc Netw; 2019 Jun; 17(6):676-686. PubMed ID: 31200362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Standardized structured reports for gastrointestinal tumors].
    Hewer E; Rump A; Langer R
    Pathologe; 2022 Feb; 43(1):57-62. PubMed ID: 34609569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: a retrospective cohort analysis.
    Klein J; Tran W; Watkins E; Vesprini D; Wright FC; Look Hong NJ; Ghandi S; Kiss A; Czarnota GJ
    BMC Cancer; 2019 Apr; 19(1):306. PubMed ID: 30943923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innovative Synoptic Reporting With Seven-Point Sampling Protocol to Improve Detection Rate of Microvascular Invasion in Hepatocellular Carcinoma.
    Liao B; Liu L; Wei L; Wang Y; Chen L; Cao Q; Zhou Q; Xiao H; Chen S; Peng S; Li S; Kuang M
    Front Oncol; 2021; 11():726239. PubMed ID: 34804920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synoptic pathology reporting for thyroid cancer: a review and institutional experience.
    Lam E; Vy N; Bajdik C; Strugnell SS; Walker B; Wiseman SM
    Expert Rev Anticancer Ther; 2013 Sep; 13(9):1073-9. PubMed ID: 24053206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in breast cancer grading: the effect of creating awareness through laboratory-specific and pathologist-specific feedback reports in 16 734 patients with breast cancer.
    van Dooijeweert C; van Diest PJ; Baas IO; van der Wall E; Deckers IA
    J Clin Pathol; 2020 Dec; 73(12):793-799. PubMed ID: 32276993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of pathology reporting is crucial for cancer care and registration: a baseline assessment for breast cancers diagnosed in Belgium in 2008.
    De Schutter H; Van Damme N; Colpaert C; Galant C; Lambein K; Cornelis A; Neven P; Van Eycken E
    Breast; 2015 Apr; 24(2):143-52. PubMed ID: 25572136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal adjuvant endocrine treatment of ER+/HER2+ breast cancer patients by age at diagnosis: A population-based cohort study.
    Dackus GMHE; Jóźwiak K; Sonke GS; van der Wall E; van Diest PJ; Hauptmann M; Siesling S; Linn SC
    Eur J Cancer; 2018 Feb; 90():92-101. PubMed ID: 29274928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional variation in breast cancer treatment in the Netherlands and the role of external peer review: a cohort study comprising 63,516 women.
    Kilsdonk MJ; van Dijk BA; Otter R; van Harten WH; Siesling S
    BMC Cancer; 2014 Aug; 14():596. PubMed ID: 25129126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Completeness of breast cancer operative reports in a community care setting.
    Eng JL; Baliski CR; McGahan C; Cai E
    Breast; 2017 Oct; 35():91-97. PubMed ID: 28689055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Neoadjuvant Chemotherapy on Breast Cancer Subtype: Does Subtype Change and, if so, How? : IHC Profile and Neoadjuvant Chemotherapy.
    De La Cruz LM; Harhay MO; Zhang P; Ugras S
    Ann Surg Oncol; 2018 Nov; 25(12):3535-3540. PubMed ID: 29981025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Closing the personalized medicine information gap: HER2 test documentation practice.
    Ferrusi IL; Earle CC; Trudeau M; Leighl NB; Pullenayegum E; Khong H; Hoch JS; Marshall DA
    Am J Manag Care; 2013 Jan; 19(1):838-44. PubMed ID: 23379747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated Generation of Synoptic Reports from Narrative Pathology Reports in University Malaya Medical Centre Using Natural Language Processing.
    Tan WM; Teoh KH; Ganggayah MD; Taib NA; Zaini HS; Dhillon SK
    Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35453927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The administration of adjuvant chemo(-immuno) therapy in the post ACOSOG-Z0011 era; a population based study.
    Poodt IGM; Rots ML; Vugts G; van Dalen T; Kuijer A; Vriens BEPJ; Nieuwenhuijzen GAP; Schipper RJ
    Eur J Surg Oncol; 2018 Aug; 44(8):1151-1156. PubMed ID: 29580733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electronic capture and communication of synoptic cancer data elements from pathology reports: results of the Reporting Pathology Protocols 2 (RPP2) project.
    Hassell L; Aldinger W; Moody C; Winters S; Gerlach K; Schwenn M; Perriello D
    J Registry Manag; 2009; 36(4):117-24; quiz 163-5. PubMed ID: 20795553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer.
    van Ramshorst MS; van der Heiden-van der Loo M; Dackus GM; Linn SC; Sonke GS
    Breast Cancer Res Treat; 2016 Jul; 158(2):361-71. PubMed ID: 27357813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact on Quality of Documentation and Workload of the Introduction of a National Information Standard for Tumor Board Reporting.
    Ebben KCWJ; Sieswerda MS; Luiten EJT; Heijns JB; van der Pol CC; Bessems M; Honkoop AH; Hendriks MP; Verloop J; Verbeek XAAM
    JCO Clin Cancer Inform; 2020 Apr; 4():346-356. PubMed ID: 32324446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.